Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin L Lampson

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk DiseaseMatthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Positive Selection Screen for Natural Product β-Catenin InactivatorsMatthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Science Advances|February 6, 2021
Targeting oncoproteins with a positive selection assay for protein degradersVidyasagar Koduri, Leslie Duplaquet, Benjamin L Lampson, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2024
Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk DiseaseMatthew S Davids, Christine E Ryan, Benjamin L Lampson, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Positive Selection Screen for Natural Product β-Catenin InactivatorsMatthew W Boudreau, Vitor F Freire, Sophie C Corbett, et al.
Science Advances|February 6, 2021
Targeting oncoproteins with a positive selection assay for protein degradersVidyasagar Koduri, Leslie Duplaquet, Benjamin L Lampson, et al.
Pageof 3